Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Catalent Pharma Solutions LimogesCatalent Pharma Solutions Limoges
VS
Johnson & Johnson Innovative MedicineJohnson & Johnson Innovative Medicine
Catalent Pharma Solutions Limoges

Catalent Pharma Solutions Limoges

48, Rue Gilles de Roberval, Limoges, 87280, FR

Last Update: 04/02/2026

View Profile
Between 750 and 799
https://www.catalent.com/
754/1000Fair

One of the very few development and manufacturing partners with the capacity and technical expertise across multiple cell types at both clinical and commercial scale. Catalent has the leadership position in the biotech industry, gene therapy offering, and delivers compr...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0
Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine

N/A

Last Update: 31/03/2026

View Profile
807/1000Good

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with co...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:37,729
Subsidiaries:10
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Catalent Pharma Solutions Limoges

Catalent Pharma Solutions Limoges

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Catalent Pharma Solutions Limoges in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Johnson & Johnson Innovative Medicine in 2026.

Incidents

Incident History - Catalent Pharma Solutions Limoges (X = Date, Y = Severity)

Catalent Pharma Solutions Limoges cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Johnson & Johnson Innovative Medicine (X = Date, Y = Severity)

Johnson & Johnson Innovative Medicine cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Catalent Pharma Solutions Limoges

Catalent Pharma Solutions Limoges

Incidents
No explicit notable incidents reported.
Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine

Incidents
No explicit notable incidents reported.

FAQ

Between Catalent Pharma Solutions Limoges company and Johnson & Johnson Innovative Medicine company, which one has the best AI Cybersecurity Score ?
Between Catalent Pharma Solutions Limoges company and Johnson & Johnson Innovative Medicine company, which one has experienced more cyber incidents in the past ?
Between Catalent Pharma Solutions Limoges company and Johnson & Johnson Innovative Medicine company, which one has experienced more cyber incidents this year ?
Between Catalent Pharma Solutions Limoges company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one ransomware attack ?
Between Catalent Pharma Solutions Limoges company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one data breach ?
Between Catalent Pharma Solutions Limoges company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one targeted cyberattack ?
Between Catalent Pharma Solutions Limoges company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one vulnerability ?
Between Catalent Pharma Solutions Limoges company and Johnson & Johnson Innovative Medicine company, which one holds the most compliance certifications ?
Between Catalent Pharma Solutions Limoges company and Johnson & Johnson Innovative Medicine company, which one holds the fewest compliance certifications ?
Between Catalent Pharma Solutions Limoges company and Johnson & Johnson Innovative Medicine company, which one has the most subsidiaries ?
Between Catalent Pharma Solutions Limoges company and Johnson & Johnson Innovative Medicine company, which one has the largest number of employees ?
Between Catalent Pharma Solutions Limoges and Johnson & Johnson Innovative Medicine, which company holds both SOC 2 Type 1 certifications ?
Between Catalent Pharma Solutions Limoges and Johnson & Johnson Innovative Medicine, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Catalent Pharma Solutions Limoges or Johnson & Johnson Innovative Medicine ?
Which company is PCI DSS compliant - Catalent Pharma Solutions Limoges or Johnson & Johnson Innovative Medicine ?
Between Catalent Pharma Solutions Limoges and Johnson & Johnson Innovative Medicine, which company complies with HIPAA regulations for healthcare data ?
Between Catalent Pharma Solutions Limoges and Johnson & Johnson Innovative Medicine, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-61246
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60455
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60439
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60373
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
CVE-2026-60372
SUMMARY

Vulnerability in the Oracle Platform Security for Java product of Oracle Fusion Middleware (component: Centralized Thirdparty Jars). Supported versions that are affected are 12.2.1.4.0 and 14.1.2.0.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Platform Security for Java. Successful attacks of this vulnerability can result in takeover of Oracle Platform Security for Java. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

PUBLISHED
Date2026-07-22
UPDATED
Date2026-07-22
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
3.9